Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02376387Completed

Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation

Role: collaborator

NCT00310401Phase 2Completed

The Effect of Nebulized Albuterol on Donor Oxygenation

Role: collaborator

NCT01680744Not ApplicableCompleted

The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup

Role: collaborator

NCT01140035Not ApplicableCompleted

Intensive Insulin Therapy in Deceased Donors

Role: collaborator

All 4 trials loaded